185 related articles for article (PubMed ID: 38474117)
1. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF.
Vernet Machado Bressan Wilke M; Iop GD; Faqueti L; Lemos da Silva LA; Kubaski F; Poswar FO; Michelin-Tirelli K; Randon D; Borelli WV; Giugliani R; Schwartz IVD
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474117
[TBL] [Abstract][Full Text] [Related]
2. Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS/MS.
Tang C; Jia X; Tang F; Liu S; Jiang X; Zhao X; Sheng H; Peng M; Liu L; Huang Y
Clin Biochem; 2021 Jan; 87():79-84. PubMed ID: 33188770
[TBL] [Abstract][Full Text] [Related]
3. Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease.
Hurvitz N; Dinur T; Becker-Cohen M; Cozma C; Hovakimyan M; Oppermann S; Demuth L; Rolfs A; Abramov A; Zimran A; Revel-Vilk S
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234327
[TBL] [Abstract][Full Text] [Related]
4. Gaucher Disease Diagnosis Using Lyso-Gb1 on Dry Blood Spot Samples: Time to Change the Paradigm?
Dinur T; Bauer P; Beetz C; Kramp G; Cozma C; Iurașcu MI; Becker-Cohen M; Istaiti M; Rolfs A; Zimran A; Revel-Vilk S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163551
[TBL] [Abstract][Full Text] [Related]
5. Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review.
Revel-Vilk S; Fuller M; Zimran A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998334
[TBL] [Abstract][Full Text] [Related]
6. Glucosylsphingosine (Lyso-Gb1) as a reliable biomarker in Gaucher disease: a narrative review.
Giuffrida G; Markovic U; Condorelli A; Calafiore V; Nicolosi D; Calagna M; Grasso S; Ragusa MTV; Gentile J; Napolitano M
Orphanet J Rare Dis; 2023 Feb; 18(1):27. PubMed ID: 36782327
[TBL] [Abstract][Full Text] [Related]
7. Glucosylsphingosine (Lyso-Gb
Gayed MM; Jung SH; Huggins E; Rodriguez-Rassi E; DeArmey S; Kishnani PS; Stiles AR
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499264
[TBL] [Abstract][Full Text] [Related]
8. An observational study to investigate the relationship between plasma glucosylsphingosine (lyso-Gb1) concentration and treatment outcomes of patients with Gaucher disease in Japan.
Ida H; Watanabe Y; Sagara R; Inoue Y; Fernandez J
Orphanet J Rare Dis; 2022 Nov; 17(1):401. PubMed ID: 36329499
[TBL] [Abstract][Full Text] [Related]
9. Glucosylsphingosine but not Saposin C, is the target antigen in Gaucher disease-associated gammopathy.
Nair S; Bar N; Xu ML; Dhodapkar M; Mistry PK
Mol Genet Metab; 2020 Apr; 129(4):286-291. PubMed ID: 32044242
[TBL] [Abstract][Full Text] [Related]
10. Impact of Long-Term Enzyme Replacement Therapy on Glucosylsphingosine (Lyso-Gb1) Values in Patients with Type 1 Gaucher Disease: Statistical Models for Comparing Three Enzymatic Formulations.
Dinur T; Grittner U; Revel-Vilk S; Becker-Cohen M; Istaiti M; Cozma C; Rolfs A; Zimran A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299318
[TBL] [Abstract][Full Text] [Related]
11. Treatment Efficiency in Gaucher Patients Can Reliably Be Monitored by Quantification of Lyso-Gb1 Concentrations in Dried Blood Spots.
Cozma C; Cullufi P; Kramp G; Hovakimyan M; Velmishi V; Gjikopulli A; Tomori S; Fischer S; Oppermann S; Grittner U; Bauer P; Beetz C; Rolfs A
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605119
[TBL] [Abstract][Full Text] [Related]
12. Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease.
Lukas J; Cozma C; Yang F; Kramp G; Meyer A; Neßlauer AM; Eichler S; Böttcher T; Witt M; Bräuer AU; Kropp P; Rolfs A
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053611
[TBL] [Abstract][Full Text] [Related]
13. Expanding the clinical utility of glucosylsphingosine for Gaucher disease.
Saville JT; McDermott BK; Chin SJ; Fletcher JM; Fuller M
J Inherit Metab Dis; 2020 May; 43(3):558-563. PubMed ID: 31707742
[TBL] [Abstract][Full Text] [Related]
14. Glucosylsphingosine is a key biomarker of Gaucher disease.
Murugesan V; Chuang WL; Liu J; Lischuk A; Kacena K; Lin H; Pastores GM; Yang R; Keutzer J; Zhang K; Mistry PK
Am J Hematol; 2016 Nov; 91(11):1082-1089. PubMed ID: 27441734
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic Study Using Time-of-Flight Mass Spectrometry Reveals Novel Urinary Biomarkers for Gaucher Disease Type 1.
Menkovic I; Boutin M; Alayoubi A; Curado F; Bauer P; Mercier FE; Auray-Blais C
J Proteome Res; 2022 May; 21(5):1321-1329. PubMed ID: 35349295
[TBL] [Abstract][Full Text] [Related]
16. Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials.
Elstein D; Mellgard B; Dinh Q; Lan L; Qiu Y; Cozma C; Eichler S; Böttcher T; Zimran A
Mol Genet Metab; 2017 Sep; 122(1-2):113-120. PubMed ID: 28851512
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease.
Dinur T; Bauer P; Beetz C; Cozma C; Becker-Cohen M; Istaiti M; Rolfs A; Skrahina V; Zimran A; Revel-Vilk S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835356
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of a Urinary Profile of Biomarkers in Gaucher Disease Type 1 Patients Using Tandem Mass Spectrometry.
Menkovic I; Boutin M; Alayoubi A; Curado F; Bauer P; Mercier FE; Auray-Blais C
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741225
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach.
Menkovic I; Boutin M; Alayoubi A; Mercier FE; Rivard GÉ; Auray-Blais C
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114153
[TBL] [Abstract][Full Text] [Related]
20. Plasma glucosylsphingosine correlations with baseline disease burden and response to eliglustat in two clinical trials of previously untreated adults with Gaucher disease type 1.
Peterschmitt MJ; Foster MC; Ji AJ; Zajdel MB; Cox GF
Mol Genet Metab; 2023 Mar; 138(3):107527. PubMed ID: 36739645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
